Willem Weimar

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

Teun van Gelder, Luuk B. Hilbrands, Yves Vanrenterghem et al. · Transplantation · 1999 · 540 citations

Medicine, Pharmacokinetics, Pharmacology +17

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*

Michael Hale, Andrew Nicholls, Roy Bullingham et al. · Clinical Pharmacology & Therapeutics · 1998 · 399 citations

Medicine, Pharmacokinetics, Pharmacology +16

High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

Lennaert C. P. Borra, Joke I. Roodnat, J. Kal et al. · Nephrology Dialysis Transplantation · 2010 · 242 citations · Full text

Medicine, Immunology, Nephrology +17

Effect of One-HLA-DR-Antigen–Matched and Completely HLA-DR–Mismatched Blood Transfusions on Survival of Heart and Kidney Allografts

Emma L. Lagaaij, I. Philip H. Hennemann, Marieke Ruigrok et al. · New England Journal of Medicine · 1989 · 223 citations

Medicine, Immunology, Surgery +17

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

Raimund Margreiter, Willem Weimar, Jacques Dantal et al. · American Journal of Transplantation · 2005 · 218 citations

Medicine, Nephrology, Pharmacology +17